Portfolio News
Sofinnova MD Start
Moon Surgical announces CE Mark for its commercial Maestro System
Easy to use and scalable: The Maestro System’s approach to laparoscopy
PARIS and SAN FRANCISCO, September 19, 2023 -- Moon Surgical, a French-American pioneer in collaborative robotics, announced today that the latest version of its Maestro System is CE Marked under the Medical Device Regulation (EU) 2017/745.
In addition to its scalability and refined aesthetics, this updated Maestro boasts several improvements over its predecessor, such as:
- Automated set-up with bedside guidance, and tailored surgeon configurations
- Cloud connectivity for a more integrated Maestro OR and ecosystem experience
- Surgeon guided hands-free scope control for optimized vision capabilities
"This latest evolution of the Maestro System focuses on manufacturing scalability, together with increased capability and has simplified both usability and training," said Anne Osdoit, CEO of Moon Surgical, and a Partner at Sofinnova Partners. “It seamlessly integrates into OR workflows while giving surgeons more confidence and delivering an improved surgical experience.”
With its new category of robotic surgery, Moon Surgical aims not only to broaden the scale at which robotics are used but also to improve the quality of care for patients and the bottom line for healthcare providers. The Maestro System is designed to provide an accessible and enhanced version of traditional laparoscopy to over 18 million patients undergoing soft tissue procedures annually who currently lack the benefits of robotic surgical platforms.
The initial version of the Maestro System obtained its CE Mark earlier this April.
About Moon Surgical
Moon Surgical, based in Paris, France, and San Francisco, California, believes the future of the operating room lies in the hands of the empowered surgeon.
By equipping surgeons with complete control, renewed confidence, and technology adaptable to any situation, Moon Surgical strives to improve efficiency in operating rooms and provide better surgical care for patients. The minimalistic, co-manipulation Maestro System uses tomorrow's technology to deliver these vital skills to surgeons, today.
Contact
Investors and Media: info@moonsurgical.com
Moon Surgical® and Maestro® are registered trademarks of Moon Surgical, SAS
Related News
NanoPhoria Bioscience secures €83.5 Million Series A to advance breakthrough heart failure therapy and expand portfolio for novel Nano-in-Micro delivery platform
AAVantgarde Announces FDA Orphan Drug Designation and UK CTA approval for AAVB-039 for the Treatment of Stargardt Disease
Sitryx receives FDA clearance of IND application for SYX-5219 for the treatment of atopic dermatitis
Inventiva Appoints Andrew Obenshain as Chief Executive Officer
ADC Innovator Myricx Bio Appoints Boston-based Mohit Rawat as CEO and Expands Team in US and UK